From New York Post · · 40s
Cefepime linked to higher death risk in adults
New study shows common antibiotic may raise death risk in older adults
In brief
New study shows common antibiotic may raise death risk in older adults Cefepime's death risk is tied to dosing, not the drug itself Originally reported by New York Post.
Quick answers
- Why higher risk?
- Underdosing and overdosing may cause harm, not the drug itself
- What is the key takeaway from Cefepime linked to higher death risk in adults?
- Cefepime's death risk is tied to dosing, not the drug itself
Cefepime risks
New study links cefepime to higher death risk in adults
“The antibiotic, cefepime, which is used to treat bacterial infections like pneumonia, UTIs, and skin infections, is typically administered via injection by healthcare providers in a clinical setting.”
Study details
11,726 patients showed 6.6% death rate with cefepime vs 6.2% with other antibiotics
“Across all trials, 778 deaths occurred among 11,726 patients (6.6%) given cefepime, compared to 6.2% of patients given another antibiotic.”
Why higher risk?
Underdosing and overdosing may cause harm, not the drug itself
“In this case, it correctly pointed out that febrile neutropenia is itself a big cause of death in this population”
Dosing challenge
Finding the right dose is hard: higher doses kill more bacteria but increase side effects
“Researchers said finding the right dose of cefepime can be challenging, as higher doses may improve its ability to kill bacteria while also increasing the risk of toxic side effects.”
Expert insight
AI could help determine optimal dosing for cefepime
“I also think there may be a role for AI here in determining the exact right dose, as well as assessing outcome”
In short
Cefepime's death risk is tied to dosing, not the drug itself
